Immunotherapy in myeloma: Why, when and how?
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000100 |
| _version_ | 1827332298423402496 |
|---|---|
| author | Niels W.C.J. van de Donk |
| author_facet | Niels W.C.J. van de Donk |
| author_sort | Niels W.C.J. van de Donk |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:57:03Z |
| format | Article |
| id | doaj.art-5ad318008e884fb88705c2e3c5fdd15f |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:57:03Z |
| publishDate | 2018-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-5ad318008e884fb88705c2e3c5fdd15f2024-03-03T03:51:22ZengWileyHemaSphere2572-92412018-06-01212112410.1097/HS9.0000000000000100201806002-00047Immunotherapy in myeloma: Why, when and how?Niels W.C.J. van de Donk0Department of Hematology, VU University Medical Center, Amsterdam, The Netherlandshttp://journals.lww.com/10.1097/HS9.0000000000000100 |
| spellingShingle | Niels W.C.J. van de Donk Immunotherapy in myeloma: Why, when and how? HemaSphere |
| title | Immunotherapy in myeloma: Why, when and how? |
| title_full | Immunotherapy in myeloma: Why, when and how? |
| title_fullStr | Immunotherapy in myeloma: Why, when and how? |
| title_full_unstemmed | Immunotherapy in myeloma: Why, when and how? |
| title_short | Immunotherapy in myeloma: Why, when and how? |
| title_sort | immunotherapy in myeloma why when and how |
| url | http://journals.lww.com/10.1097/HS9.0000000000000100 |
| work_keys_str_mv | AT nielswcjvandedonk immunotherapyinmyelomawhywhenandhow |